Extrawell Pharmaceutical to Sell Shares for HK$15.4 Million
MT Newswires Live
Aug 15
Extrawell Pharmaceutical (HKG:0858) agreed to sell 160 million shares to three separate investors for HK$15.4 million in net proceeds, according to a Hong Kong bourse filing Friday.
Shares of the pharmaceuticals company rose over 3% in pre-market trade Friday.
The company plans to issue 30 million shares to Tsang Kwong Chiu; 20 million shares to Zhang Xiaojia; and 110 million shares to Fudan Health International.
All of the shares will be sold at HK$0.097 apiece for net proceeds of HK$2.9 million, HK$1.9 million, and HK$10.6 million, respectively.
The shares represent 1.24%, 0.83%, and 4.4% of the company's enlarged issued share capital.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.